Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because they are ...

CEO Zhang Ligang (left) and COO Huang Feiyan of iKang. Photo: Courtesy of iKang iKang Healthcare Group, Inc's initial public offering was priced at $16.50 on April 9, 2014, giving the largest provider ...

iKang Healthcare could find the going tough in New York with its newly announced plan for a Nasdaq IPO, at least based on the lackluster record for others from China's medical sector. iKang has become ...

Traders cheer after the company provides an update on its bid to go private. Here's what investors need to know. After it announced that it has reached an agreement to extend the deadline for its ...

Chinese healthcare solutions company iKang Healthcare Group (ADR) (NASDAQ: KANG) a revised merger bid on Monday morning and shares are rising. The offer could give investors the confidence to demand ...

China's iKang Healthcare ($KANG) wants to go private in a management-led $1.1 billion offer that would see it delist from the U.S., making it among a handful of ...

iKang Healthcare ( KANG) is the largest provider in China's private preventative healthcare services market, with a 2013 market share of 12.3%. The private healthcare market in China is currently ...

iKang Healthcare Group reported solid Q2 earnings, beating both top and bottom line expectations. The company is undervalued, with a forward PEG of 0.65. The company has plenty of growth ahead, as ...

This morning shares of iKang, one of China's largest healthcare services providers, that trade via their ADS issues on the NASDAQ have jumped almost 18% on getting a "go private" offer from a group ...

After it announced that it has reached an agreement to extend the deadline for its transaction to be taken private, shares of iKang Healthcare Group (NASDAQ: KANG) , a provider of preventative ...

iKang Healthcare's IPO could enjoy modest success due to its position as a top Chinese clinic operator, but it will have to overcome broader investor indifference to Chinese healthcare stocks. iKang ...